Hyaluronan is required for cranial neural crest cells migration and craniofacial development

Developmental Dynamics

Volumn 241, Issue 2, 2012, Pages 294-302

  Casini, Paola ^a   Nardi, Irma ^a   Ori, Michela ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

CD44; Craniofacial development; Extracellular matrix; Has1; Has2; Hyaluronan; Neural crest cell; Xenopus

Indexed keywords

HYALURONAN SYNTHASE 1; HYALURONAN SYNTHASE 2; HYALURONIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL MATURATION; CELL MIGRATION; CELL SURVIVAL; CRANIOFACIAL DEVELOPMENT; GENE FUNCTION; GENE SILENCING; NEURAL CREST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL MOVEMENT; CRANIOFACIAL ABNORMALITIES; GENE KNOCKDOWN TECHNIQUES; GLUCURONOSYLTRANSFERASE; GLYCOSYLTRANSFERASES; HYALURONIC ACID; MEMBRANE PROTEINS; NEURAL CREST; XENOPUS LAEVIS; XENOPUS PROTEINS;

VERTEBRATA;

EID: 84856218940     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.23715     Document Type: Article

References (48)

1. Aszodi A, Legate KR, Nakchbandi I, Fassler R. 2006. What mouse mutants teach us about extracellular matrix function. Annu Rev Cell Dev Biol 22: 591-621.
2. Bakkers J, Kramer C, Pothol J, Quadvlieg NEM, Spaink HP, Hammerschmidt M. 2004. Has2 is required upstream of Rac1 to govern dorsal migration of lateral cells during zebrafish gastrulation. Development 131: 525-537.
3. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, Jones M, Jackson DG. 1999. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144: 789-801.
4. Bourguignon LY, Zhu H, Chu A, Iida N, Zhang L, Hung MC. 1997. Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J Biol Chem 272: 27913-27918.
5. Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN, Fawcett JW, McMahon SB. 2002. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416: 636-640.
6. Brecht M, Mayer U, Schlosser E, Prehm P. 1986. Increased hyaluronate synthesis is required for fibroblast detachment and mitosis. Biochem J 239: 445-450.
7. Bronner-Fraser M. 1993. Mechanisms of neural crest cell migration. Bioessays 15: 221-230.
8. Camenisch TD, Spider AP, Brehm-Gibson T, Biesterfeldt J, Augustine M, Calabro A, Kubalak S, Klewer S, McDonald JA. 2000. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest 106: 349-360.
9. Casini P. Ori M, Avenoso A, D'Ascola A, Traina P, Mattina W, Perris R, Campo GM, Calatroni A, Nardi I, Campo S. 2008. Identification and gene expression of versican during early development of Xenopus. Int J Dev Biol 52: 993-998.
10. Casini P, Nardi I, Ori M. 2010. RHAMM mRNA expression in proliferating and migrating cells of the developing central nervous system. Gene Expr Patterns 10: 93-97.
11. Contreras E, Gaete M, Sánchez N, Carrasco H, Larraín J. 2009. Early requirement of Hyaluronan for tail regeneration in Xenopus tadpoles. Development 136: 2987-2996.
12. Etchevers HC, Amiel J, Lyonnet S. 2006. Molecular bases of human neurocristopathies. Adv Exp Med Biol 589: 213-234.
13. Harland RM. 1991. In situ hybridization: an improved whole-mount method for Xenopus embryos. Methods Cell Biol 36: 685-695.
14. Hascall VC, Majors AK, De La Motte CA, Evanko SP, Wang A, Drazba JA, Strong SA, Wight TN. 2004. Intracellular hyaluronan: a new frontier for inflammation? Biochim Biophys Acta 1673: 3-12.
15. Hensey C, Gautier J. 1998. Programmed cell death during Xenopus development: a spatio-temporal analysis. Dev Biol 203: 36-48.
16. Jiang D, Liang J, Noble PW. 2007. Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 23: 435-461.
17. Jiang D, Liang J, Noble PW. 2011. Hyaluronan as an immune regulator in human diseases. Physiol Rev 91: 221-264.
18. Kaneko T, Saito H, Toya M, Satio T, Nakahara K, Hiroi M. 2000. Hyaluronic acid inhibits apoptosis in granulosa cells via CD44. J Assist Reprod Genet 17: 580-585.
19. Levin M. 2004. A novel immunohistochemical method for evaluation of antibody specificity and detection of labile targets in biological tissue. J Biochem Biophys Methods 58: 85-96.
20. Li Y, Toole BP, Dealy CN, Kosher RA. 2007. Hyaluronan in limb morphogenesis. Dev Biol 305: 411-420.
21. Matsumoto K, Li Y, Jakuba C, Sugiyama Y, Sayo T, Okuno M, Dealy CN, Toole BP, Takeda J, Yamaguchi Y, Kosher RA. 2009. Conditional inactivation of Has2 reveals a crucial role for hyaluronan in skeletal growth, patterning, chondrocyte maturation and joint formation in the developing limb. Development 136: 2825-2835.
22. McDonald JA, Camenisch TD. 2002. Hyaluronan: genetic insights into the complex biology of a simple polysaccharide. Glycoconj J 19: 331-339.
23. Misra S, Heldin P, Hascall VC, Karamanos NK, Skandalis SS, Markwald RR, Ghatak S. 2011. Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J 278: 1429-1443.
24. Mjaatvedt CH, Yamamura H, Capehart AA, Turner D, Markwald RR. 1998. The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev Biol 202: 56-66.
25. Nardini M, Ori M, Vigetti D, Gornati R, Nardi I, Perris R. 2004. Regulated gene expression of hyaluronan synthases during Xenopus laevis development. Gene Expr Pattern 43: 303-308.
26. Nedvetzki S, Gonen E, Assayag N, Reich R, Williams RO, Thurmond RL, Huang JF, Neudecker BA, Wang FS, Turley EA, Naor D. 2004. RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy. Proc Natl Acad Sci USA 101: 18081-18088.
27. Nieuwkoop PD, Faber J. 1956. Normal table of Xenopus laevis (Daudin), a systematical and chronological survey of the development from the fertilized egg till the end of metamorphosis. Amsterdam: North-Holland Publishing Company.
28. Ohwada C, Nakaseko C, Koizumi M, Takeuchi M, Ozawa S, Naito M, Tanaka H, Oda K, Cho R, Nishimura M, Saito Y. 2008. CD44 and hyaluronan engagement promotes dexamethasone resistance in human myeloma cells. Eur J Haematol 80: 245-250.
29. Ori M, Nardini M, Casini P, Perris R, Nardi I. 2006. XHas2 activity is required during somitogenesis and precursor cell migration in Xenopus development. Development 133: 631-640.
30. Ozeki H, Ogura Y, Hirabayashi Y, Shimada S. 2001. Suppression of lens stalk cell apoptosis by hyaluronic acid leads to faulty separation of the lens vesicle. Exp Eye Res 72: 63-70.
31. Perris R, Krotoski D, Lallier T, Domingo C, Sorrell JM, Bronner-Fraser M. 1991. Spatial and temporal changes in the distribution of proteoglycans during avian neural crest development. Development 111: 583-599.
32. Prestwich GD, Kuo JW. 2008. Chemically-modified HA for therapy and regenerative medicine. Curr Pharm Biotechnol 9: 242-245.
33. Protin U, Schweighoffer T, Jochum W, Hilberg F. 1999. CD44-Deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets. J Immunol 163: 4917-4923.
34. Reisoli E, De Lucchini S, Nardi I, Ori M. 2010. Serotonin 2B receptor signaling is required for craniofacial morphogenesis and jaw joint formation in Xenopus. Development 137: 2927-2937.
35. Sadaghiani B, Thiébaud CH. 1987. Neural crest development in the Xenopus laevis embryo, studied by interspecific transplantation and scanning electron microscopy. Dev Biol 124: 91-110.
36. Schmalfeldt M, Bandtlow CE, Dours-Zimmermann MT, Winterhalter KH, Zimmermann DR. 2000. Brain derived versican V2 is a potent inhibitor of axonal growth. J Cell Sci 113: 807-816.
37. Sive H, Grainger R, Harland R. 2000. Early development of Xenopus laevis: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
38. Tammi RH, Ronkko S, Agren UM, Tammi M. 1994. Distribution of hyaluronan in bull reproductive organs. J Histochem Cytochem 42: 1479-1486.
39. Tammi RH, Passi AG, Rilla K, Karousou E, Vigetti D, Makkonen K, Tammi MI. 2011. Transcriptional and post-translational regulation of hyaluronan synthesis. FEBS J 278: 1419-1428.
40. Taneyhill LA, Bronner-Fraser M. 2005. Recycling signals in the neural crest. J Biol 4: 10.
41. Tobin JL, Di Franco M, Eichers E, May-Simera H, Garcia M, Yan J, Quinlan R, Justice MJ, Hennekam RC, Briscoe J, Tada M, Mayor R, Burns AJ, Lupski JR, Hammond P, Beales PL. 2008. Inhibition of neural crest migration underlies craniofacial dysmorphology and Hirschsprung's disease in Bardet-Biedl syndrome. Proc Natl Acad Sci USA 105: 6714-6719.
42. Toole BP. 1991. Proteoglycans and hyaluronan in morphogenesis and differentiation. In: Hay E, editor. Cell biology of extracellular matrix. New York: Plenum Press. p 305-341.
43. Toole BP. 1998. Hyaluronan in morphogenesis and tissue remodelling. Glycoforum: science of hyaluronan today.
44. Toole BP. 2000. Hyaluronan is not just a goo! J Clin Invest 106: 335-336.
45. Toole BP. 2001. Hyaluronan in morphogenesis. Semin Cell Dev Biol 12: 79-87.
46. Toole BP, Slomiany MG. 2008. Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells. Semin Cancer Biol 18: 244-250.
47. Toole BP, Trelstad RL. 1971. Hyaluronate production and removal during corneal development in the chick. Dev Biol 26: 28-35.
48. Tzircotis G, Thorne RF, Isacke CM. 2005. Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding. J Cell Sci 118: 5119-5128.